120 Participants Needed

Airway Protection Rehabilitation for Parkinson's Disease

Recruiting at 1 trial location
MT
Overseen ByMichelle Troche, PhD
Age: 18+
Sex: Any
Trial Phase: Phase 2
Sponsor: Teachers College, Columbia University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

Airway protective disorders are a prevalent and progressive consequence of Parkinson's Disease (PD), and often result in aspiration pneumonia which is the leading cause of death in PD. Despite this, a large number of patients with PD do not access specialized services to address these critical deficits. The investigators will examine the comparative effectiveness of a novel treatment paradigm delivered in-person versus via telehealth in persons with PD, as well as the role of patient burden and treatment adherence on outcomes; thus, the proposed research is relevant to public health and in line with NIH's mission to identify novel, efficacious, and accessible rehabilitation strategies for short- and long-term improvement of dysfunctional airway protection in PD.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Is Expiratory Muscle Strength Training (EMST) safe for humans?

Research indicates that Expiratory Muscle Strength Training (EMST) is generally safe for humans, as studies have not reported significant safety concerns related to its use in various conditions, including Parkinson's Disease and other neurological and respiratory conditions.12345

How does the treatment Expiratory Muscle Strength Training + Cough Skill Training differ from other treatments for Parkinson's Disease?

This treatment is unique because it combines exercises to strengthen breathing muscles and improve cough skills, which can help with swallowing and airway protection in Parkinson's Disease. Unlike many treatments that focus on medication, this approach uses physical training to enhance respiratory function and can be delivered via telehealth, making it more accessible.56789

What data supports the effectiveness of the treatment Expiratory Muscle Strength Training + Cough Skill Training for Parkinson's Disease?

Research shows that Expiratory Muscle Strength Training (EMST) can improve cough function and swallowing safety in people with Parkinson's Disease. Additionally, combining EMST with air stacking techniques has been found to enhance peak cough flow, which is important for airway protection.15678

Who Is on the Research Team?

MT

Michelle Troche, PhD

Principal Investigator

Teachers College, Columbia University

Are You a Good Fit for This Trial?

This trial is for people aged 50-90 with Parkinson's Disease who have trouble swallowing or coughing but aren't currently getting therapy for it. They must be diagnosed by a specialist and can't have other neurological disorders, recent smoking history, breathing diseases, severe depression or dementia.

Inclusion Criteria

I have trouble swallowing thin liquids or coughing effectively.
I have Parkinson's disease, stages II-IV, confirmed by a specialist.
I am not currently undergoing any exercise-based therapy for swallowing.
See 1 more

Exclusion Criteria

I have had head or neck cancer in the past.
My blood pressure is not well-controlled.
I have a history of lung problems like COPD.
See 5 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intensive Treatment

Participants undergo four weeks of intensive Expiratory Muscle Strength Training (EMST) and Cough Skill Training (CST) delivered in-person or via telehealth

4 weeks
4 visits (in-person or virtual)

Maintenance Treatment

Participants continue with a long-term EMST+CST maintenance program offered in-person or via telehealth

1 year
Assessments at 6 and 12 months

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Expiratory Muscle Strength Training + Cough Skill Training
Trial Overview The study tests whether training to strengthen the muscles used in breathing out and coughing helps protect the airway better than usual care. It compares results of doing these exercises in-person versus via telehealth to see which is more effective.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: TelehealthExperimental Treatment1 Intervention
Group II: In-personActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Teachers College, Columbia University

Lead Sponsor

Trials
27
Recruited
6,100+

National Institute of Neurological Disorders and Stroke (NINDS)

Collaborator

Trials
1,403
Recruited
655,000+

Purdue University

Collaborator

Trials
239
Recruited
72,200+

Published Research Related to This Trial

In a study involving 56 participants with Parkinson's Disease, neither expiratory muscle strength training (EMST) nor sensorimotor training of airway protection (smTAP) showed significant changes in vocal fold bowing or the presence of vocal fold lesions, indicating that these treatments do not negatively impact vocal fold health.
Both EMST and smTAP were found to be safe interventions, as they did not lead to the development of vocal fold lesions despite involving forceful exhalation and repetitive coughing.
Cough and Swallowing Therapy and Their Effects on Vocal Fold Bowing and Laryngeal Lesions.Doruk, C., Curtis, JA., Dakin, AE., et al.[2023]
The study demonstrated that both Expiratory Muscle Strength Training (EMST) and Cough Skill Training (CST) can be effectively delivered via telehealth, with participants completing treatments in about 17.5 minutes per session.
Participants showed significant improvements in airway protection measures, specifically maximum expiratory pressure (pMEP) and peak expiratory flow rate (PEFR), indicating that telehealth can enhance access to important therapies for individuals with neurodegenerative movement disorders.
Rehabilitation of Airway Protection in Individuals With Movement Disorders: A Telehealth Feasibility Study.Sevitz, JS., Borders, JC., Dakin, AE., et al.[2023]
After 3 months of expiratory muscle strength training (EMST), participants with Parkinson's disease showed a 19% improvement in maximum expiratory pressure (MEP), indicating that EMST is effective for enhancing respiratory function.
Following a 3-month detraining period, MEP slightly declined by 2% but remained 17% above baseline levels, suggesting that while some benefits of EMST are retained, maintenance programs may be necessary to sustain improvements in muscle strength and swallowing safety.
Detraining outcomes with expiratory muscle strength training in Parkinson disease.Troche, MS., Rosenbek, JC., Okun, MS., et al.[2021]

Citations

Cough and Swallowing Therapy and Their Effects on Vocal Fold Bowing and Laryngeal Lesions. [2023]
Rehabilitation of Airway Protection in Individuals With Movement Disorders: A Telehealth Feasibility Study. [2023]
Detraining outcomes with expiratory muscle strength training in Parkinson disease. [2021]
Functional outcomes associated with expiratory muscle strength training: narrative review. [2014]
Effects of Expiratory Muscle Training and Air Stacking on Peak Cough Flow in Individuals with Parkinson's Disease. [2021]
Expiratory Muscle Strength Training in Multiple System Atrophy: A Pilot Study. [2023]
High elevation training mask as a respiratory muscle strength training tool for dysphagia. [2019]
Expiratory Muscle Strength Training in patients After Total Laryngectomy; A Feasibility Pilot Study. [2022]
Effect of expiratory muscle strength training intervention on the maximum expiratory pressure and quality of life of patients with Parkinson disease. [2018]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security